Clin Psychopharmacol Neurosci.  2014 Dec;12(3):196-202. 10.9758/cpn.2014.12.3.196.

Serotonin and Mental Disorders: A Concise Review on Molecular Neuroimaging Evidence

• Lin SH
• Lee LT
• Yang YK

• KMID: 2279929
• DOI: http://doi.org/10.9758/cpn.2014.12.3.196

Abstract

Serotonin is one of the most important neurotransmitters influencing mental health and, thus, is a potential target for pharmaco-logical treatments. Functional neuroimaging techniques, such as positron-emission tomography (PET) and single photon emission computed tomography (SPECT), could provide persuasive evidence for the association between mental disorders and serotonin. In this concise review, we focus on evidence of the links between serotonin and major depressive disorders, as well as other mood disorders, anxiety disorders, schizophrenia, addiction, attention deficit hyperactivity disorder (ADHD), and autism.

Keyword

Serotonin; Mental disorders; Positron-emission tomography; Single photon emission computed tomography

MeSH Terms

Anxiety Disorders
Attention Deficit Disorder with Hyperactivity
Autistic Disorder
Depressive Disorder, Major
Functional Neuroimaging
Mental Disorders*
Mental Health
Mood Disorders
Neuroimaging*
Neurotransmitter Agents
Positron-Emission Tomography
Schizophrenia
Serotonin*
Tomography, Emission-Computed, Single-Photon
Neurotransmitter Agents
Serotonin